Transcriptional Characterization and Functional Analysis of Long Non-Coding RNA/Protein-Coding Gene Pairs Encoded in the Human Genome

Total Page:16

File Type:pdf, Size:1020Kb

Transcriptional Characterization and Functional Analysis of Long Non-Coding RNA/Protein-Coding Gene Pairs Encoded in the Human Genome Transcriptional characterization and functional analysis of long non-coding RNA/protein-coding gene pairs encoded in the human genome Inaugural-Dissertation to obtain the academic degree Doctor rerum naturalium (Dr. rer. nat.) submitted to the Department of Biology, Chemistry and Pharmacy of Freie Universität Berlin by Anne-Susann Musahl from Berlin Berlin, 2015 ii The present work was carried out from March 2012 until April 2015 at the Max Planck Institute for Molecular Genetics under the supervision of Dr. Ulf Andersson Ørom. 1st Reviewer: Dr. Ulf Andersson Ørom 2nd Reviewer:Prof. Dr. Markus Wahl Date of Defence: 10.07.2015 iii Für Küsschen und das Entchen. iv v Acknowledgements I would like to thank my PhD advisor Dr. Ulf Ørom for giving me the opportunity to work in his lab and on this exciting project. Ulf provided me with guidance and support but also gave me the freedom to develop and follow own research ideas. I also want to thank Prof. Dr. Markus Wahl for reviewing this PhD thesis. Many thanks goes to my friends and colleagues in the lab: Dubravka Vučićević, Thomas Conrad, Evgenia Ntini, Annita Louloupi, Alexander Kiefer, Julia Liz, Maja Gehre, An- tonia Hilbig and Masha Kenda, you guys provided such a friendly and helpful working environment that enabled me to finish this PhD work. Special thanks goes to Dusa, Thomas and Evgenia for many insightful scientific discussions and their endless technical and moral support to pass all big and small problems that emerged in the last three years. Also, this work would never have been possible without the help of my co-authors at the Max Planck Institute and in Paris and Villejuif (France), therefore I would like to thank Annalisa Marsico, Ruping Sun, Marcus W. Albrecht, Guido Kroemer, Oliver Kepp, Xing Huang and Sylvie Rusakiewicz. Besonders dankbar bin ich meinen Eltern, für ihre dauerhafte Unterstützung und Er- mutigung ohne die meine schulische und universitäre Ausbildung nicht möglich gewesen wäre. Last, but certainly not least I would like to endlessly thank Marcus for always standing at my side and his continuous encouragement. Your love, friendship and support means everything to me. vi Acknowledgements Contents vii Contents Acknowledgements v Abbreviations xiii Abstract xvii Zusammenfassung xix 1 Introduction 1 1.1 Preface ...................................... 1 1.2 Encoding of genetic information in the human genome ........... 1 1.3 The transcription process ........................... 2 1.4 Transcriptional regulatory motifs ....................... 4 1.4.1 Enhancers ................................ 5 1.4.2 Promoters ................................ 6 1.4.2.1 Proximal promoter ...................... 6 1.4.2.2 Core promoter ........................ 6 1.4.2.3 Core promoter classes .................... 8 1.4.3 Silencers ................................. 9 1.4.4 Insulators ................................ 10 1.5 Transcription of the human genome ...................... 10 1.5.1 Bidirectional expression of PCGs ................... 10 1.5.2 Inherent promoter bidirectionality .................. 11 1.5.3 Transcription at enhancers ....................... 12 1.5.4 Similarity of transcription initiation at promoters and enhancers . 13 1.6 ncRNA species encoded in the human genome ................ 13 1.6.1 RNAs functioning in protein synthesis ................ 14 1.6.2 RNAs functioning in RNA processing ................ 14 1.6.3 RNAs functioning in regulation of RNA expression ......... 14 1.6.4 RNAs with diverse functions - long ncRNAs ............. 14 1.7 Functionality of long ncRNAs ......................... 15 1.7.1 Classification of long ncRNAs ..................... 15 viii Contents 1.7.2 Characteristics of long ncRNAs .................... 15 1.7.3 Functions of long ncRNAs ....................... 17 1.7.4 Association of long ncRNAs with PCG promoters .......... 19 1.8 Human tumor suppressors ........................... 21 1.8.1 Functionality of the retinoblastoma protein ............. 22 1.8.2 Functionality of calreticulin ...................... 23 1.9 Aims of the thesis ................................ 25 2 Materials and Methods 27 2.1 Materials .................................... 27 2.1.1 Instrumentation ............................ 27 2.1.2 Consumables .............................. 28 2.1.3 Chemicals ................................ 29 2.1.4 Buffers, solutions and media ...................... 30 2.1.5 Molecular biology kits ......................... 31 2.1.6 Enzymes and proteins ......................... 31 2.1.7 Plasmids ................................. 31 2.1.8 Antibodies ............................... 32 2.1.9 Oligonucleotides ............................ 32 2.1.10 Cell lines ................................ 35 2.1.11 Bacterial strain ............................. 36 2.1.12 Software ................................. 36 2.2 Methods ..................................... 36 2.2.1 Molecular biology methods ...................... 36 2.2.1.1 Isolation of genomic DNA .................. 36 2.2.1.2 Polymerase chain reaction .................. 37 2.2.1.3 Site-directed mutagenesis PCR ............... 37 2.2.1.4 Agarose gel electrophoresis ................. 38 2.2.1.5 DNA gel extraction ..................... 38 2.2.1.6 Determination of nucleic acid concentration and purity . 38 2.2.1.7 A-tailing of PCR products ................. 38 2.2.1.8 TOPO TA cloning ...................... 39 2.2.1.9 Restriction digest ...................... 39 2.2.1.10 Dephosphorylation of vectors ................ 39 2.2.1.11 Ligation of DNA ....................... 39 2.2.1.12 Generation of chemically competent E. coli cells ..... 40 2.2.1.13 Transformation of E. coli cells ............... 40 2.2.1.14 Colony PCR ......................... 40 2.2.1.15 Bacterial culture ....................... 40 2.2.1.16 Plasmid isolation and analytical digest ........... 41 Contents ix 2.2.1.17 Sanger sequencing ...................... 41 2.2.1.18 Diethylpyrocarbonate-treatment of dH2O ......... 41 2.2.1.19 RNA isolation of human cells ................ 41 2.2.1.20 DNase I treatment of RNA ................. 41 2.2.1.21 Complementary DNA synthesis ............... 42 2.2.1.22 Quantitative real-time PCR ................. 42 2.2.1.23 Next generation sequencing ................. 43 2.2.2 Cell culture methods .......................... 43 2.2.2.1 Culture of human cell lines ................. 43 2.2.2.2 Transfection of human cells ................. 44 2.2.2.3 Luciferase assay ....................... 44 2.2.2.4 Preparation of cellular extracts ............... 45 2.2.2.5 Fractionation of cells ..................... 45 2.2.2.6 Generation of stable cell lines using CRISPR ....... 45 2.2.3 Protein biochemical methods ..................... 46 2.2.3.1 Determination of protein concentration .......... 46 2.2.3.2 SDS polyacrylamide gel electrophoresis .......... 46 2.2.3.3 Western blot ......................... 46 2.2.3.4 Immunocytochemistry .................... 47 2.2.3.5 Cell surface immunocytochemistry and flow cytometry .. 47 2.2.3.6 Macrophage uptake assay .................. 47 2.2.4 Computational methods ........................ 48 2.2.4.1 Filtering of ncRNA/PCG pairs ............... 48 2.2.4.2 Conservation analysis of promoters ............. 48 2.2.4.3 Analysis of next generation sequencing data ........ 48 2.2.4.4 Determination of immunofluorescence intensity ...... 49 2.2.5 Statistical data analysis ........................ 49 3 Results 51 3.1 Long ncRNA/PCG pairs encoded in the human genome .......... 52 3.1.1 Association of long ncRNA genes with PCGs ............ 52 3.1.2 Functional categories of PCGs expressed from bidirectional long ncRNA/PCG promoters ........................ 52 3.1.3 Final set of bidirectionally expressed long ncRNA/PCG pairs ... 54 3.1.4 Conservation of bidirectional ncRNA/PCG promoters ....... 54 3.2 Expression of long ncRNA/PCG pairs from bidirectional promoters .... 55 3.2.1 Polymerase II occupancy at bidirectional promoters ......... 55 3.2.2 Capacity of long ncRNA/PCG promoters to initiate transcription bidirectionally .............................. 56 3.2.3 In vivo expression levels of ncRNA/PCG pairs ........... 57 x Contents 3.2.4 Regulation of long ncRNA expression by the exosome complex .. 59 3.3 The bidirectional ncRNA-RB1/RB1 promoter ................ 60 3.3.1 Effect of mutations on ncRNA-RB1/RB1 promoter activity .... 60 3.3.1.1 Mutations within transcription factor binding sites .... 60 3.3.1.2 Mutations within core promoter elements ......... 61 3.4 Transcript characteristics of ncRNA-RB1 ................... 64 3.4.1 Transcript structure .......................... 64 3.4.2 Cellular localization .......................... 64 3.5 Gene regulatory effects of ncRNA-RB1 .................... 65 3.5.1 Cellular depletion of ncRNA-RB1 and RB1 using dsiRNAs .... 65 3.5.2 Effect of ncRNA-RB1 knock-down on RB1 expression levels .... 66 3.5.3 Effect of ncRNA-RB1 and RB1 knock-down on the cellular tran- scriptome ................................ 66 3.5.4 Confirmation of ncRNA target genes by qRT-PCR ......... 68 3.5.5 Double knock-down of ncRNA-RB1 and RB1 ............ 68 3.5.6 Overexpression of ncRNA-RB1 .................... 69 3.5.7 Calreticulin as a ncRNA-RB1 target gene .............. 69 3.5.7.1 Regulation of calreticulin protein levels .......... 69 3.5.7.2 Knock-down of ncRNA-RB1 by antisense oligonucleotides 71 3.5.7.3 Knock-out of ncRNA-RB1 by genome editing using CRISPR 71 3.5.7.4 Knock-down of ncRNA-RB1 in U2OS cells ........ 72 3.6 Mechanistic insights into the regulation of calreticulin by ncRNA-RB1
Recommended publications
  • Atrazine and Cell Death Symbol Synonym(S)
    Supplementary Table S1: Atrazine and Cell Death Symbol Synonym(s) Entrez Gene Name Location Family AR AIS, Andr, androgen receptor androgen receptor Nucleus ligand- dependent nuclear receptor atrazine 1,3,5-triazine-2,4-diamine Other chemical toxicant beta-estradiol (8R,9S,13S,14S,17S)-13-methyl- Other chemical - 6,7,8,9,11,12,14,15,16,17- endogenous decahydrocyclopenta[a]phenanthrene- mammalian 3,17-diol CGB (includes beta HCG5, CGB3, CGB5, CGB7, chorionic gonadotropin, beta Extracellular other others) CGB8, chorionic gonadotropin polypeptide Space CLEC11A AW457320, C-type lectin domain C-type lectin domain family 11, Extracellular growth factor family 11, member A, STEM CELL member A Space GROWTH FACTOR CYP11A1 CHOLESTEROL SIDE-CHAIN cytochrome P450, family 11, Cytoplasm enzyme CLEAVAGE ENZYME subfamily A, polypeptide 1 CYP19A1 Ar, ArKO, ARO, ARO1, Aromatase cytochrome P450, family 19, Cytoplasm enzyme subfamily A, polypeptide 1 ESR1 AA420328, Alpha estrogen receptor,(α) estrogen receptor 1 Nucleus ligand- dependent nuclear receptor estrogen C18 steroids, oestrogen Other chemical drug estrogen receptor ER, ESR, ESR1/2, esr1/esr2 Nucleus group estrone (8R,9S,13S,14S)-3-hydroxy-13-methyl- Other chemical - 7,8,9,11,12,14,15,16-octahydro-6H- endogenous cyclopenta[a]phenanthren-17-one mammalian G6PD BOS 25472, G28A, G6PD1, G6PDX, glucose-6-phosphate Cytoplasm enzyme Glucose-6-P Dehydrogenase dehydrogenase GATA4 ASD2, GATA binding protein 4, GATA binding protein 4 Nucleus transcription TACHD, TOF, VSD1 regulator GHRHR growth hormone releasing
    [Show full text]
  • Genomics and Genetics of Gonadotropin Beta-Subunit Genes: Unique FSHB and Duplicated LHB/CGB Loci
    Molecular and Cellular Endocrinology 329 (2010) 4–16 Contents lists available at ScienceDirect Molecular and Cellular Endocrinology journal homepage: www.elsevier.com/locate/mce Review Genomics and genetics of gonadotropin beta-subunit genes: Unique FSHB and duplicated LHB/CGB loci Liina Nagirnaja a, Kristiina Rull a,b,c, Liis Uusküla a, Pille Hallast a, Marina Grigorova a,c, Maris Laan a,∗ a Institute of Molecular and Cell Biology, University of Tartu, Riia St. 23, 51010 Tartu, Estonia b Department of Obstetrics and Gynecology, University of Tartu, Puusepa 8 G2, 51014 Tartu, Estonia c Estonian Biocentre, Riia St. 23b, 51010 Tartu, Estonia article info abstract Article history: The follicle stimulating hormone (FSH), luteinizing hormone (LH) and chorionic gonadotropin (HCG) play Received 5 January 2010 a critical role in human reproduction. Despite the common evolutionary ancestry and functional related- Received in revised form 13 April 2010 ness of the gonadotropin hormone beta (GtHB) genes, the single-copy FSHB (at 11p13) and the multi-copy Accepted 26 April 2010 LHB/CGB genes (at 19q13.32) exhibit locus-specific differences regarding their genomic context, evolu- tion, genetic variation and expressional profile. FSHB represents a conservative vertebrate gene with a Keywords: unique function and it is located in a structurally stable gene-poor region. In contrast, the primate-specific Gonadotropin hormones LHB/CGB gene cluster is located in a gene-rich genomic context and demonstrates an example of evolu- FSHB LHB tionary young and unstable genomic region. The gene cluster is shaped by a constant balance between HCG beta selection that acts on specific functions of the loci and frequent gene conversion events among dupli- Gene duplications cons.
    [Show full text]
  • Role of Amylase in Ovarian Cancer Mai Mohamed University of South Florida, [email protected]
    University of South Florida Scholar Commons Graduate Theses and Dissertations Graduate School July 2017 Role of Amylase in Ovarian Cancer Mai Mohamed University of South Florida, [email protected] Follow this and additional works at: http://scholarcommons.usf.edu/etd Part of the Pathology Commons Scholar Commons Citation Mohamed, Mai, "Role of Amylase in Ovarian Cancer" (2017). Graduate Theses and Dissertations. http://scholarcommons.usf.edu/etd/6907 This Dissertation is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact [email protected]. Role of Amylase in Ovarian Cancer by Mai Mohamed A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Department of Pathology and Cell Biology Morsani College of Medicine University of South Florida Major Professor: Patricia Kruk, Ph.D. Paula C. Bickford, Ph.D. Meera Nanjundan, Ph.D. Marzenna Wiranowska, Ph.D. Lauri Wright, Ph.D. Date of Approval: June 29, 2017 Keywords: ovarian cancer, amylase, computational analyses, glycocalyx, cellular invasion Copyright © 2017, Mai Mohamed Dedication This dissertation is dedicated to my parents, Ahmed and Fatma, who have always stressed the importance of education, and, throughout my education, have been my strongest source of encouragement and support. They always believed in me and I am eternally grateful to them. I would also like to thank my brothers, Mohamed and Hussien, and my sister, Mariam. I would also like to thank my husband, Ahmed.
    [Show full text]
  • Pivotal Role of the Transcriptional Co-Activator YAP in Trophoblast Stemness of the Developing Human Placenta
    Pivotal role of the transcriptional co-activator YAP in trophoblast stemness of the developing human placenta Gudrun Meinhardta, Sandra Haidera, Victoria Kunihsa, Leila Saleha, Jürgen Pollheimera, Christian Fialab, Szabolcs Heteyc, Zsofia Feherc, Andras Szilagyic, Nandor Gabor Thanc,d,e, and Martin Knöflera,1 aDepartment of Obstetrics and Gynaecology, Reproductive Biology Unit, Medical University of Vienna, A-1090 Vienna, Austria; bGynmed Clinic, A-1150 Vienna, Austria; cSystems Biology of Reproduction Lendulet Group, Institute of Enzymology, Research Centre for Natural Sciences, H-1117 Budapest, Hungary; dMaternity Private Clinic of Obstetrics and Gynecology, H-1126 Budapest, Hungary; and e1st Department of Pathology and Experimental Cancer Research, Semmelweis University, H-1085 Budapest, Hungary Edited by R. Michael Roberts, University of Missouri, Columbia, MO, and approved April 30, 2020 (received for review February 12, 2020) Various pregnancy complications, such as severe forms of pre- developing placenta, might cause malperfusion and, as a conse- eclampsia or intrauterine growth restriction, are thought to arise quence, oxidative-stress provoking placental dysfunction (9–11). from failures in the differentiation of human placental tropho- Besides fetal and maternal aberrations, failures in placentation blasts. Progenitors of the latter either develop into invasive are thought to arise from abnormal trophoblast differentiation extravillous trophoblasts, remodeling the uterine vasculature, or (12). Indeed, cytotrophoblasts (CTBs) isolated from pre- fuse into multinuclear syncytiotrophoblasts transporting oxygen eclamptic placentae exhibit defects in in vitro EVT formation and nutrients to the growing fetus. However, key regulatory (13). Likewise, CTB growth and/or cell fusion were shown to be factors controlling trophoblast self-renewal and differentiation impaired in cultures established from placental tissues of preg- have been poorly elucidated.
    [Show full text]
  • Stockholm 2011
    From genes to gestation Special Interest Groups Early Pregnancy and Reproductive Genetics 3 July 2011 Stockholm, Sweden 3 From genes to gestation Stockholm, Sweden 3 July 2011 Organised by Special Interest Groups Early Pregnancy and Reproductive Genetics Contents Course coordinators, course description and target audience Page 5 Programme Page 7 Introduction to ESHRE Page 9 Speakers’ contributions Preparing embryonic development in male gametes – Bradley Cairns (USA) Page 17 What do we know about genes affecting embryo implantation? – Nick Macklon (United Kingdom) Page 32 What is epigenetics and how can it affect embryo development? ‐ Jorn Walter (Germany) Page 46 Small RNAs and control of retrotransposons during gametogenesis and early development ‐ Martin Matzuk (USA) Page 52 Chorionic gonadotropin beta‐gene variants as a risk factor for recurrent miscarriages ‐ Maris Laan (Estonia) Page 68 Genomic changes detected by array CGH in human embryos with developmental defects – Evica Rajcan‐Separovic (Canada) Page 79 Non invasive prenatal diagnosis using cell‐free nucleic acids ‐ Diana Bianchi (USA) Page 90 Genetics of molar pregnancies – Rosemary Fisher (United Kingdom) Page 101 Gene therapy for the fetus: how far have we come? – Donald Peebles (United Kingdom) Page 114 Upcoming ESHRE Campus Courses Page 127 Notes Page 128 Page 3 of 135 Page 4 of 135 Course coordinators Ole B. Christiansen (Denmark, SIG Early Pregnancy) and Stephane Viville (France, SIG Reproductive Genetics) Course description The course is basic to advanced. The course will give an overview of which genes are known or believed to influence fertilization, embryo implantation and early embryo development before and after implantation. Potential pathophysiologic pathways linking genetics and abnormal fertilization, implantation and embryo development will be discussed.
    [Show full text]
  • Human and Chimpanzee Chorionic Gonadotropin Beta Genes Pille Hallast1, Janna Saarela2, Aarno Palotie3,4,5 and Maris Laan*1
    BMC Evolutionary Biology BioMed Central Research article Open Access High divergence in primate-specific duplicated regions: Human and chimpanzee Chorionic Gonadotropin Beta genes Pille Hallast1, Janna Saarela2, Aarno Palotie3,4,5 and Maris Laan*1 Address: 1Department of Biotechnology, Institute of Molecular and Cell Biology, University of Tartu, Riia 23, 51010 Tartu, Estonia, 2Department of Molecular Medicine, National Public Health Institute, Haartmaninkatu 8, 00290 Helsinki, Finland, 3Finnish Genome Center, Biomedicum Helsinki, University of Helsinki, Haartmaninkatu 8, 00290 Helsinki, Finland, 4The Broad Institute of Harvard and MIT, Cambridge Center, Cambridge, MA 02142, USA and 5Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK Email: Pille Hallast - [email protected]; Janna Saarela - [email protected]; Aarno Palotie - [email protected]; Maris Laan* - [email protected] * Corresponding author Published: 7 July 2008 Received: 29 August 2007 Accepted: 7 July 2008 BMC Evolutionary Biology 2008, 8:195 doi:10.1186/1471-2148-8-195 This article is available from: http://www.biomedcentral.com/1471-2148/8/195 © 2008 Hallast et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: Low nucleotide divergence between human and chimpanzee does not sufficiently explain the species-specific morphological, physiological and behavioral traits. As gene duplication is a major prerequisite for the emergence of new genes and novel biological processes, comparative studies of human and chimpanzee duplicated genes may assist in understanding the mechanisms behind primate evolution.
    [Show full text]
  • Anti-Hcg (Beta 2 Epitope) Antibody [INN-Hcg-22] (ARG23029)
    Product datasheet [email protected] ARG23029 Package: 250 μg anti-hCG (beta 2 epitope) antibody [INN-hCG-22] Store at: -20°C Summary Product Description Mouse Monoclonal antibody [INN-hCG-22] recognizes hCG (beta 2 epitope) Mouse anti Human chorionic gonadotrophin antibody, clone INN-hCG-22 recognizes the beta subunit of human choriogonadotrophin (hCG), also known as chorionic gonadotrophin. hCGβ is a 165 amino acid ~18 kDa hormone involved in the stimulation of steroid production essential to the maintenance of pregnancy.Mouse anti Human chorionic gonadotrophin antibody, clone INN-hCG-22 shows a strong reaction in RIA with intact hCG and hCGβ and some reactivity with human luteinizing hormone (12%) and b-hLH (34%). No reaction with human follicle-stimulating hormone, thyroid-stimulating hormone , a- hCG or a-hLH.Affinity constant = 1.6 x 109m (Ka) . Tested Reactivity Hu Tested Application ELISA, IHC-P, WB Host Mouse Clonality Monoclonal Clone INN-hCG-22 Isotype IgG1 Target Name hCG (beta 2 epitope) Antigen Species Human Immunogen hCG. Conjugation Un-conjugated Alternate Names hCGB; CGB5; CGB7; CGB3; Chorionic gonadotrophin chain beta; CGB8; CG-beta; Choriogonadotropin subunit beta Application Instructions Application table Application Dilution ELISA 1:100 - 1:500 IHC-P Assay-dependent WB Assay-dependent Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Calculated Mw 18 kDa Properties Form Liquid Purification Purification with Protein A. Buffer PBS and 0.09% Sodium azide www.arigobio.com 1/2 Preservative 0.09% Sodium azide Concentration 1 mg/ml Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week.
    [Show full text]
  • Anti-CGB Monoclonal Antibody, Clone INN-Hcg-53 (CABT-49228MH) This Product Is for Research Use Only and Is Not Intended for Diagnostic Use
    Anti-CGB monoclonal antibody, clone INN-hCG-53 (CABT-49228MH) This product is for research use only and is not intended for diagnostic use. PRODUCT INFORMATION Product Overview Clone INN-hCG-53 recognises epitope c2 on hCG. It does not recognise free hCG subunits. Western Blotting Clone INN-hCG-53 detects a band of about 47-50 kDa under non-reducing conditions. Specificity CGB Isotype IgG1 Source/Host Mouse Species Reactivity Human Clone INN-hCG-53 Conjugate Unconjugated Applications ELISA; WB Format Purified IgG - liquid Size 500 μg Preservative See individual product datasheet Storage Store at +4°C or at -20°C if preferred. This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use. Warnings For research purposes only GENE INFORMATION Gene Name CGB chorionic gonadotropin, beta polypeptide [ Homo sapiens (human) ] Official Symbol CGB Synonyms CGB; chorionic gonadotropin, beta polypeptide; CGB3; CGB5; CGB7; CGB8; hCGB; choriogonadotropin subunit beta; CG-beta; chorionic gonadotropin beta chain; chorionic 45-1 Ramsey Road, Shirley, NY 11967, USA Email: [email protected] Tel: 1-631-624-4882 Fax: 1-631-938-8221 1 © Creative Diagnostics All Rights Reserved gonadotrophin chain beta; chorionic gonadotropin beta subunit; chorionic gonadotropin beta Entrez Gene ID 1082 Protein Refseq NP_000728 UniProt ID P01215 Chromosome Location 19q13.32 Pathway Glycoprotein hormones; Metabolism of proteins; Peptide hormone biosynthesis; Peptide hormone metabolism; Function hormone activity; 45-1 Ramsey Road, Shirley, NY 11967, USA Email: [email protected] Tel: 1-631-624-4882 Fax: 1-631-938-8221 2 © Creative Diagnostics All Rights Reserved.
    [Show full text]
  • The Study of the Expression of CGB1 and CGB2 in Human Cancer Tissues
    G C A T T A C G G C A T genes Article The Study of the Expression of CGB1 and CGB2 in Human Cancer Tissues Piotr Białas * , Aleksandra Sliwa´ y , Anna Szczerba y and Anna Jankowska Department of Cell Biology, Poznan University of Medical Sciences, Rokietnicka 5D, 60-806 Pozna´n,Poland; [email protected] (A.S.);´ [email protected] (A.S.); [email protected] (A.J.) * Correspondence: [email protected]; Tel.: +48-6185-4-71-89 These authors contributed equally to this work. y Received: 14 August 2020; Accepted: 15 September 2020; Published: 17 September 2020 Abstract: Human chorionic gonadotropin (hCG) is a well-known hormone produced by the trophoblast during pregnancy as well as by both trophoblastic and non-trophoblastic tumors. hCG is built from two subunits: α (hCGα) and β (hCGβ). The hormone-specific β subunit is encoded by six allelic genes: CGB3, CGB5, CGB6, CGB7, CGB8, and CGB9, mapped to the 19q13.32 locus. This gene cluster also encompasses the CGB1 and CGB2 genes, which were originally considered to be pseudogenes, but as documented by several studies are transcriptionally active. Even though the protein products of these genes have not yet been identified, based on The Cancer Genome Atlas (TCGA) database analysis we showed that the mutual presence of CGB1 and CGB2 transcripts is a characteristic feature of cancers of different origin, including bladder urothelial carcinoma, cervical squamous cell carcinoma, esophageal carcinoma, head and neck squamous cell carcinoma, ovarian serous cystadenocarcinoma, lung squamous cell carcinoma, pancreatic adenocarcinoma, rectum adenocacinoma, testis germ cell tumors, thymoma, uterine corpus endometrial carcinoma and uterine carcinosarcoma.
    [Show full text]
  • Non-Canonical TAF Complexes Regulate Active Promoters in Human Embryonic Stem Cells
    University of Massachusetts Medical School eScholarship@UMMS Program in Gene Function and Expression Publications and Presentations Molecular, Cell and Cancer Biology 2012-11-13 Non-canonical TAF complexes regulate active promoters in human embryonic stem cells Glenn A. Maston University of Massachusetts Medical School Et al. Let us know how access to this document benefits ou.y Follow this and additional works at: https://escholarship.umassmed.edu/pgfe_pp Part of the Genetics and Genomics Commons Repository Citation Maston GA, Zhu LJ, Chamberlain L, Lin L, Fang M, Green MR. (2012). Non-canonical TAF complexes regulate active promoters in human embryonic stem cells. Program in Gene Function and Expression Publications and Presentations. https://doi.org/10.7554/eLife.00068. Retrieved from https://escholarship.umassmed.edu/pgfe_pp/211 This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Program in Gene Function and Expression Publications and Presentations by an authorized administrator of eScholarship@UMMS. For more information, please contact [email protected]. RESEARCH ARTICLE elife.elifesciences.org Non-canonical TAF complexes regulate active promoters in human embryonic stem cells Glenn A Maston1,2, Lihua Julie Zhu1,3, Lynn Chamberlain1,2, Ling Lin1,2, Minggang Fang1,2, Michael R Green1,2* 1Programs in Gene Function and Expression and Molecular Medicine, University of Massachusetts Medical School, Worcester, United States; 2Howard Hughes Medical Institute, Chevy Chase, United States; 3Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, United States Abstract The general transcription factor TFIID comprises the TATA-box-binding protein (TBP) and approximately 14 TBP-associated factors (TAFs).
    [Show full text]
  • View a Copy of This Licence, Visit
    Robertson et al. BMC Biology (2020) 18:103 https://doi.org/10.1186/s12915-020-00826-z RESEARCH ARTICLE Open Access Large-scale discovery of male reproductive tract-specific genes through analysis of RNA-seq datasets Matthew J. Robertson1,2, Katarzyna Kent3,4,5, Nathan Tharp3,4,5, Kaori Nozawa3,5, Laura Dean3,4,5, Michelle Mathew3,4,5, Sandra L. Grimm2,6, Zhifeng Yu3,5, Christine Légaré7,8, Yoshitaka Fujihara3,5,9,10, Masahito Ikawa9, Robert Sullivan7,8, Cristian Coarfa1,2,6*, Martin M. Matzuk1,3,5,6 and Thomas X. Garcia3,4,5* Abstract Background: The development of a safe, effective, reversible, non-hormonal contraceptive method for men has been an ongoing effort for the past few decades. However, despite significant progress on elucidating the function of key proteins involved in reproduction, understanding male reproductive physiology is limited by incomplete information on the genes expressed in reproductive tissues, and no contraceptive targets have so far reached clinical trials. To advance product development, further identification of novel reproductive tract-specific genes leading to potentially druggable protein targets is imperative. Results: In this study, we expand on previous single tissue, single species studies by integrating analysis of publicly available human and mouse RNA-seq datasets whose initial published purpose was not focused on identifying male reproductive tract-specific targets. We also incorporate analysis of additional newly acquired human and mouse testis and epididymis samples to increase the number of targets identified. We detected a combined total of 1178 genes for which no previous evidence of male reproductive tract-specific expression was annotated, many of which are potentially druggable targets.
    [Show full text]
  • Whole Exome Sequencing of a Single Osteosarcoma Case—Integrative Analysis with Whole Transcriptome RNA-Seq Data
    Reimann et al. Human Genomics 2014, 8:20 http://www.humgenomics.com/content/8/1/20 PRIMARY RESEARCH Open Access Whole exome sequencing of a single osteosarcoma case—integrative analysis with whole transcriptome RNA-seq data Ene Reimann1,2*, Sulev Kõks1,2, Xuan Dung Ho3,4, Katre Maasalu3,5 and Aare Märtson3,5 Abstract Background: Osteosarcoma (OS) is a prevalent primary malignant bone tumour with unknown etiology. These highly metastasizing tumours are among the most frequent causes of cancer-related deaths. Thus, there is an urgent need for different markers, and with our study, we were aiming towards finding novel biomarkers for OS. Methods: For that, we analysed the whole exome of the tumorous and non-tumour bone tissue from the same patient with OS applying next-generation sequencing. For data analysis, we used several softwares and combined the exome data with RNA-seq data from our previous study. Results: In the tumour exome, we found wide genomic rearrangements, which should qualify as chromotripsis— we detected almost 3,000 somatic single nucleotide variants (SNVs) and small indels and more than 2,000 copy number variants (CNVs) in different chromosomes. Furthermore, the somatic changes seem to be associated to bone tumours, whereas germline mutations to cancer in general. We confirmed the previous findings that the most significant pathway involved in OS pathogenesis is probably the WNT/β-catenin signalling pathway. Also, the IGF1/ IGF2 and IGF1R homodimer signalling and TP53 (including downstream tumour suppressor gene EI24) pathways may have a role. Additionally, the mucin family genes, especially MUC4 and cell cycle controlling gene CDC27 may be considered as potential biomarkers for OS.
    [Show full text]